nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—BCHE—Cisplatin—germ cell cancer	0.203	0.238	CbGbCtD
Mirabegron—SLCO1A2—Methotrexate—germ cell cancer	0.124	0.145	CbGbCtD
Mirabegron—ABCB1—Dactinomycin—germ cell cancer	0.0895	0.105	CbGbCtD
Mirabegron—ALB—Methotrexate—germ cell cancer	0.0638	0.075	CbGbCtD
Mirabegron—CYP3A4—Ifosfamide—germ cell cancer	0.0633	0.0744	CbGbCtD
Mirabegron—ABCB1—Vinblastine—germ cell cancer	0.0561	0.0659	CbGbCtD
Mirabegron—CYP2D6—Vinblastine—germ cell cancer	0.0528	0.0621	CbGbCtD
Mirabegron—ABCB1—Cisplatin—germ cell cancer	0.0514	0.0604	CbGbCtD
Mirabegron—ABCB1—Etoposide—germ cell cancer	0.0505	0.0594	CbGbCtD
Mirabegron—CYP3A4—Vinblastine—germ cell cancer	0.0336	0.0395	CbGbCtD
Mirabegron—ABCB1—Methotrexate—germ cell cancer	0.0334	0.0392	CbGbCtD
Mirabegron—CYP3A4—Etoposide—germ cell cancer	0.0303	0.0356	CbGbCtD
Mirabegron—Rash papular—Ifosfamide—germ cell cancer	0.00572	0.0433	CcSEcCtD
Mirabegron—Rash macular—Ifosfamide—germ cell cancer	0.0052	0.0393	CcSEcCtD
Mirabegron—Neoplasm—Vinblastine—germ cell cancer	0.00267	0.0202	CcSEcCtD
Mirabegron—Cystitis noninfective—Bleomycin—germ cell cancer	0.00244	0.0184	CcSEcCtD
Mirabegron—Cystitis—Bleomycin—germ cell cancer	0.00241	0.0182	CcSEcCtD
Mirabegron—Bladder pain—Bleomycin—germ cell cancer	0.00226	0.0171	CcSEcCtD
Mirabegron—Cerebrovascular accident—Vinblastine—germ cell cancer	0.00219	0.0166	CcSEcCtD
Mirabegron—Leukocytoclastic vasculitis—Methotrexate—germ cell cancer	0.00206	0.0156	CcSEcCtD
Mirabegron—Neoplasm—Ifosfamide—germ cell cancer	0.00193	0.0146	CcSEcCtD
Mirabegron—Cerebrovascular accident—Bleomycin—germ cell cancer	0.00185	0.014	CcSEcCtD
Mirabegron—Atrial fibrillation—Ifosfamide—germ cell cancer	0.00163	0.0124	CcSEcCtD
Mirabegron—Osteoarthritis—Ifosfamide—germ cell cancer	0.00155	0.0117	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00152	0.0115	CcSEcCtD
Mirabegron—Urinary retention—Ifosfamide—germ cell cancer	0.00147	0.0111	CcSEcCtD
Mirabegron—Breast disorder—Ifosfamide—germ cell cancer	0.0014	0.0106	CcSEcCtD
Mirabegron—Cerebrovascular accident—Cisplatin—germ cell cancer	0.00136	0.0103	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00129	0.00977	CcSEcCtD
Mirabegron—Breast disorder—Cisplatin—germ cell cancer	0.00121	0.00913	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.0012	0.0091	CcSEcCtD
Mirabegron—Nasopharyngitis—Cisplatin—germ cell cancer	0.00119	0.00903	CcSEcCtD
Mirabegron—Infestation NOS—Ifosfamide—germ cell cancer	0.00119	0.00903	CcSEcCtD
Mirabegron—Infestation—Ifosfamide—germ cell cancer	0.00119	0.00903	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00118	0.00895	CcSEcCtD
Mirabegron—Hypertension—Vinblastine—germ cell cancer	0.00112	0.00844	CcSEcCtD
Mirabegron—Erythema multiforme—Dactinomycin—germ cell cancer	0.0011	0.00836	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.00108	0.00816	CcSEcCtD
Mirabegron—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00106	0.00801	CcSEcCtD
Mirabegron—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00105	0.00797	CcSEcCtD
Mirabegron—Urethral disorder—Ifosfamide—germ cell cancer	0.00105	0.00795	CcSEcCtD
Mirabegron—Erythema multiforme—Ifosfamide—germ cell cancer	0.00101	0.00766	CcSEcCtD
Mirabegron—Eye disorder—Ifosfamide—germ cell cancer	0.001	0.00758	CcSEcCtD
Mirabegron—Cardiac disorder—Ifosfamide—germ cell cancer	0.000994	0.00752	CcSEcCtD
Mirabegron—Cystitis noninfective—Methotrexate—germ cell cancer	0.000985	0.00746	CcSEcCtD
Mirabegron—Cystitis—Methotrexate—germ cell cancer	0.000974	0.00737	CcSEcCtD
Mirabegron—Vaginal infection—Methotrexate—germ cell cancer	0.000952	0.00721	CcSEcCtD
Mirabegron—Infestation—Etoposide—germ cell cancer	0.000942	0.00713	CcSEcCtD
Mirabegron—Infestation NOS—Etoposide—germ cell cancer	0.000942	0.00713	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000934	0.00707	CcSEcCtD
Mirabegron—Neoplasm—Methotrexate—germ cell cancer	0.000912	0.0069	CcSEcCtD
Mirabegron—Bladder pain—Methotrexate—germ cell cancer	0.000912	0.0069	CcSEcCtD
Mirabegron—Urinary tract disorder—Cisplatin—germ cell cancer	0.000912	0.0069	CcSEcCtD
Mirabegron—Connective tissue disorder—Cisplatin—germ cell cancer	0.000907	0.00687	CcSEcCtD
Mirabegron—Urethral disorder—Cisplatin—germ cell cancer	0.000905	0.00685	CcSEcCtD
Mirabegron—Constipation—Vinblastine—germ cell cancer	0.000901	0.00682	CcSEcCtD
Mirabegron—CYP3A4—urine—germ cell cancer	0.000892	0.0526	CbGeAlD
Mirabegron—Infection—Bleomycin—germ cell cancer	0.000884	0.00669	CcSEcCtD
Mirabegron—Vision blurred—Ifosfamide—germ cell cancer	0.000879	0.00665	CcSEcCtD
Mirabegron—CYP2D6—urine—germ cell cancer	0.000878	0.0517	CbGeAlD
Mirabegron—Eye disorder—Cisplatin—germ cell cancer	0.000863	0.00653	CcSEcCtD
Mirabegron—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000862	0.00652	CcSEcCtD
Mirabegron—Cardiac disorder—Cisplatin—germ cell cancer	0.000857	0.00649	CcSEcCtD
Mirabegron—Urinary tract disorder—Etoposide—germ cell cancer	0.000835	0.00632	CcSEcCtD
Mirabegron—Abdominal pain—Vinblastine—germ cell cancer	0.000833	0.00631	CcSEcCtD
Mirabegron—Urethral disorder—Etoposide—germ cell cancer	0.000829	0.00628	CcSEcCtD
Mirabegron—Infection—Dactinomycin—germ cell cancer	0.000825	0.00624	CcSEcCtD
Mirabegron—Palpitations—Ifosfamide—germ cell cancer	0.000824	0.00624	CcSEcCtD
Mirabegron—ADRB3—female gonad—germ cell cancer	0.000822	0.0484	CbGeAlD
Mirabegron—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000811	0.00614	CcSEcCtD
Mirabegron—Hypertension—Ifosfamide—germ cell cancer	0.000805	0.00609	CcSEcCtD
Mirabegron—Erythema multiforme—Etoposide—germ cell cancer	0.0008	0.00605	CcSEcCtD
Mirabegron—Arthralgia—Ifosfamide—germ cell cancer	0.000794	0.00601	CcSEcCtD
Mirabegron—Eye disorder—Etoposide—germ cell cancer	0.00079	0.00598	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000788	0.00597	CcSEcCtD
Mirabegron—Cardiac disorder—Etoposide—germ cell cancer	0.000785	0.00594	CcSEcCtD
Mirabegron—Vision blurred—Cisplatin—germ cell cancer	0.000757	0.00573	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000756	0.00573	CcSEcCtD
Mirabegron—Asthenia—Vinblastine—germ cell cancer	0.000756	0.00572	CcSEcCtD
Mirabegron—Infection—Ifosfamide—germ cell cancer	0.000756	0.00572	CcSEcCtD
Mirabegron—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000747	0.00566	CcSEcCtD
Mirabegron—Skin disorder—Ifosfamide—germ cell cancer	0.000739	0.00559	CcSEcCtD
Mirabegron—Osteoarthritis—Methotrexate—germ cell cancer	0.000732	0.00554	CcSEcCtD
Mirabegron—Diarrhoea—Vinblastine—germ cell cancer	0.000721	0.00546	CcSEcCtD
Mirabegron—Fatigue—Dactinomycin—germ cell cancer	0.000716	0.00542	CcSEcCtD
Mirabegron—Back pain—Etoposide—germ cell cancer	0.000712	0.00539	CcSEcCtD
Mirabegron—Urticaria—Bleomycin—germ cell cancer	0.000707	0.00535	CcSEcCtD
Mirabegron—Dizziness—Vinblastine—germ cell cancer	0.000697	0.00528	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000693	0.00525	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00068	0.00514	CcSEcCtD
Mirabegron—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000679	0.00514	CcSEcCtD
Mirabegron—Breast disorder—Methotrexate—germ cell cancer	0.000662	0.00501	CcSEcCtD
Mirabegron—Headache—Vinblastine—germ cell cancer	0.00066	0.005	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000657	0.00497	CcSEcCtD
Mirabegron—Abdominal pain—Dactinomycin—germ cell cancer	0.000656	0.00497	CcSEcCtD
Mirabegron—Fatigue—Ifosfamide—germ cell cancer	0.000656	0.00497	CcSEcCtD
Mirabegron—Infection—Cisplatin—germ cell cancer	0.000652	0.00493	CcSEcCtD
Mirabegron—Constipation—Ifosfamide—germ cell cancer	0.000651	0.00492	CcSEcCtD
Mirabegron—Tachycardia—Cisplatin—germ cell cancer	0.00064	0.00485	CcSEcCtD
Mirabegron—Asthenia—Bleomycin—germ cell cancer	0.000639	0.00483	CcSEcCtD
Mirabegron—Skin disorder—Cisplatin—germ cell cancer	0.000637	0.00482	CcSEcCtD
Mirabegron—Hypertension—Etoposide—germ cell cancer	0.000636	0.00481	CcSEcCtD
Mirabegron—Pruritus—Bleomycin—germ cell cancer	0.00063	0.00477	CcSEcCtD
Mirabegron—Nausea—Vinblastine—germ cell cancer	0.000626	0.00474	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000623	0.00471	CcSEcCtD
Mirabegron—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000622	0.00471	CcSEcCtD
Mirabegron—Urticaria—Ifosfamide—germ cell cancer	0.000604	0.00458	CcSEcCtD
Mirabegron—Abdominal pain—Ifosfamide—germ cell cancer	0.000601	0.00455	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000598	0.00452	CcSEcCtD
Mirabegron—Infection—Etoposide—germ cell cancer	0.000597	0.00452	CcSEcCtD
Mirabegron—Asthenia—Dactinomycin—germ cell cancer	0.000596	0.00451	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000588	0.00445	CcSEcCtD
Mirabegron—Tachycardia—Etoposide—germ cell cancer	0.000586	0.00444	CcSEcCtD
Mirabegron—Skin disorder—Etoposide—germ cell cancer	0.000584	0.00442	CcSEcCtD
Mirabegron—Diarrhoea—Dactinomycin—germ cell cancer	0.000568	0.0043	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000566	0.00429	CcSEcCtD
Mirabegron—Infestation—Methotrexate—germ cell cancer	0.000564	0.00427	CcSEcCtD
Mirabegron—Infestation NOS—Methotrexate—germ cell cancer	0.000564	0.00427	CcSEcCtD
Mirabegron—Rash—Bleomycin—germ cell cancer	0.000561	0.00425	CcSEcCtD
Mirabegron—Dermatitis—Bleomycin—germ cell cancer	0.000561	0.00424	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00056	0.00424	CcSEcCtD
Mirabegron—Asthenia—Ifosfamide—germ cell cancer	0.000546	0.00413	CcSEcCtD
Mirabegron—Pruritus—Ifosfamide—germ cell cancer	0.000538	0.00407	CcSEcCtD
Mirabegron—Nausea—Bleomycin—germ cell cancer	0.000529	0.004	CcSEcCtD
Mirabegron—Rash—Dactinomycin—germ cell cancer	0.000524	0.00396	CcSEcCtD
Mirabegron—Diarrhoea—Ifosfamide—germ cell cancer	0.000521	0.00394	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000519	0.00393	CcSEcCtD
Mirabegron—Fatigue—Etoposide—germ cell cancer	0.000518	0.00392	CcSEcCtD
Mirabegron—Constipation—Etoposide—germ cell cancer	0.000514	0.00389	CcSEcCtD
Mirabegron—Dizziness—Ifosfamide—germ cell cancer	0.000503	0.00381	CcSEcCtD
Mirabegron—Urinary tract disorder—Methotrexate—germ cell cancer	0.0005	0.00379	CcSEcCtD
Mirabegron—Urethral disorder—Methotrexate—germ cell cancer	0.000497	0.00376	CcSEcCtD
Mirabegron—SLCO1A2—telencephalon—germ cell cancer	0.000496	0.0292	CbGeAlD
Mirabegron—Nausea—Dactinomycin—germ cell cancer	0.000493	0.00373	CcSEcCtD
Mirabegron—Gastrointestinal pain—Etoposide—germ cell cancer	0.000491	0.00372	CcSEcCtD
Mirabegron—Rash—Ifosfamide—germ cell cancer	0.00048	0.00363	CcSEcCtD
Mirabegron—Dermatitis—Ifosfamide—germ cell cancer	0.000479	0.00363	CcSEcCtD
Mirabegron—Erythema multiforme—Methotrexate—germ cell cancer	0.000479	0.00363	CcSEcCtD
Mirabegron—Urticaria—Etoposide—germ cell cancer	0.000477	0.00361	CcSEcCtD
Mirabegron—Abdominal pain—Etoposide—germ cell cancer	0.000475	0.0036	CcSEcCtD
Mirabegron—Eye disorder—Methotrexate—germ cell cancer	0.000473	0.00358	CcSEcCtD
Mirabegron—Asthenia—Cisplatin—germ cell cancer	0.000471	0.00356	CcSEcCtD
Mirabegron—Cardiac disorder—Methotrexate—germ cell cancer	0.00047	0.00356	CcSEcCtD
Mirabegron—Nausea—Ifosfamide—germ cell cancer	0.000452	0.00342	CcSEcCtD
Mirabegron—Diarrhoea—Cisplatin—germ cell cancer	0.000449	0.0034	CcSEcCtD
Mirabegron—BCHE—trigeminal ganglion—germ cell cancer	0.000444	0.0261	CbGeAlD
Mirabegron—Asthenia—Etoposide—germ cell cancer	0.000431	0.00326	CcSEcCtD
Mirabegron—Back pain—Methotrexate—germ cell cancer	0.000427	0.00323	CcSEcCtD
Mirabegron—Pruritus—Etoposide—germ cell cancer	0.000425	0.00322	CcSEcCtD
Mirabegron—Vision blurred—Methotrexate—germ cell cancer	0.000416	0.00315	CcSEcCtD
Mirabegron—Rash—Cisplatin—germ cell cancer	0.000414	0.00313	CcSEcCtD
Mirabegron—Dermatitis—Cisplatin—germ cell cancer	0.000413	0.00313	CcSEcCtD
Mirabegron—Diarrhoea—Etoposide—germ cell cancer	0.000411	0.00311	CcSEcCtD
Mirabegron—Dizziness—Etoposide—germ cell cancer	0.000397	0.00301	CcSEcCtD
Mirabegron—ORM1—bone marrow—germ cell cancer	0.000395	0.0233	CbGeAlD
Mirabegron—ORM1—spinal cord—germ cell cancer	0.000394	0.0232	CbGeAlD
Mirabegron—BCHE—brainstem—germ cell cancer	0.000393	0.0231	CbGeAlD
Mirabegron—Nausea—Cisplatin—germ cell cancer	0.00039	0.00295	CcSEcCtD
Mirabegron—SLCO1A2—medulla oblongata—germ cell cancer	0.000389	0.0229	CbGeAlD
Mirabegron—Rash—Etoposide—germ cell cancer	0.000379	0.00287	CcSEcCtD
Mirabegron—Dermatitis—Etoposide—germ cell cancer	0.000379	0.00287	CcSEcCtD
Mirabegron—Headache—Etoposide—germ cell cancer	0.000376	0.00285	CcSEcCtD
Mirabegron—Arthralgia—Methotrexate—germ cell cancer	0.000375	0.00284	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000373	0.00282	CcSEcCtD
Mirabegron—ALB—adrenal gland—germ cell cancer	0.000358	0.0211	CbGeAlD
Mirabegron—Infection—Methotrexate—germ cell cancer	0.000358	0.00271	CcSEcCtD
Mirabegron—Nausea—Etoposide—germ cell cancer	0.000357	0.0027	CcSEcCtD
Mirabegron—SLCO1A2—midbrain—germ cell cancer	0.000356	0.021	CbGeAlD
Mirabegron—ORM1—endocrine gland—germ cell cancer	0.000354	0.0209	CbGeAlD
Mirabegron—Skin disorder—Methotrexate—germ cell cancer	0.00035	0.00265	CcSEcCtD
Mirabegron—BCHE—telencephalon—germ cell cancer	0.000348	0.0205	CbGeAlD
Mirabegron—SLCO1A2—spinal cord—germ cell cancer	0.000347	0.0205	CbGeAlD
Mirabegron—ABCB1—blood vessel—germ cell cancer	0.000342	0.0202	CbGeAlD
Mirabegron—BCHE—skin of body—germ cell cancer	0.000333	0.0196	CbGeAlD
Mirabegron—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000328	0.00248	CcSEcCtD
Mirabegron—Dyspepsia—Methotrexate—germ cell cancer	0.000317	0.0024	CcSEcCtD
Mirabegron—SLCO1A2—endocrine gland—germ cell cancer	0.000313	0.0184	CbGeAlD
Mirabegron—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000311	0.00235	CcSEcCtD
Mirabegron—Fatigue—Methotrexate—germ cell cancer	0.00031	0.00235	CcSEcCtD
Mirabegron—SLCO1A2—head—germ cell cancer	0.000309	0.0182	CbGeAlD
Mirabegron—SLCO1A2—testis—germ cell cancer	0.000298	0.0176	CbGeAlD
Mirabegron—ALB—testis—germ cell cancer	0.000296	0.0175	CbGeAlD
Mirabegron—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000294	0.00223	CcSEcCtD
Mirabegron—BCHE—uterus—germ cell cancer	0.000289	0.017	CbGeAlD
Mirabegron—Urticaria—Methotrexate—germ cell cancer	0.000286	0.00216	CcSEcCtD
Mirabegron—Abdominal pain—Methotrexate—germ cell cancer	0.000285	0.00215	CcSEcCtD
Mirabegron—BCHE—pituitary gland—germ cell cancer	0.000284	0.0167	CbGeAlD
Mirabegron—SLCO1A2—cerebellum—germ cell cancer	0.000275	0.0162	CbGeAlD
Mirabegron—BCHE—medulla oblongata—germ cell cancer	0.000274	0.0161	CbGeAlD
Mirabegron—CYP2D6—brainstem—germ cell cancer	0.00026	0.0153	CbGeAlD
Mirabegron—Asthenia—Methotrexate—germ cell cancer	0.000258	0.00195	CcSEcCtD
Mirabegron—Pruritus—Methotrexate—germ cell cancer	0.000255	0.00193	CcSEcCtD
Mirabegron—BCHE—adrenal gland—germ cell cancer	0.000253	0.0149	CbGeAlD
Mirabegron—BCHE—midbrain—germ cell cancer	0.00025	0.0147	CbGeAlD
Mirabegron—Diarrhoea—Methotrexate—germ cell cancer	0.000246	0.00186	CcSEcCtD
Mirabegron—BCHE—bone marrow—germ cell cancer	0.000245	0.0144	CbGeAlD
Mirabegron—ORM1—lymph node—germ cell cancer	0.000245	0.0144	CbGeAlD
Mirabegron—BCHE—spinal cord—germ cell cancer	0.000244	0.0144	CbGeAlD
Mirabegron—Dizziness—Methotrexate—germ cell cancer	0.000238	0.0018	CcSEcCtD
Mirabegron—CYP2D6—telencephalon—germ cell cancer	0.000231	0.0136	CbGeAlD
Mirabegron—Rash—Methotrexate—germ cell cancer	0.000227	0.00172	CcSEcCtD
Mirabegron—Dermatitis—Methotrexate—germ cell cancer	0.000227	0.00172	CcSEcCtD
Mirabegron—Headache—Methotrexate—germ cell cancer	0.000225	0.00171	CcSEcCtD
Mirabegron—SLCO1A2—brain—germ cell cancer	0.000224	0.0132	CbGeAlD
Mirabegron—ALB—brain—germ cell cancer	0.000222	0.0131	CbGeAlD
Mirabegron—BCHE—endocrine gland—germ cell cancer	0.00022	0.0129	CbGeAlD
Mirabegron—BCHE—head—germ cell cancer	0.000217	0.0128	CbGeAlD
Mirabegron—ALB—lymph node—germ cell cancer	0.000215	0.0127	CbGeAlD
Mirabegron—Nausea—Methotrexate—germ cell cancer	0.000214	0.00162	CcSEcCtD
Mirabegron—ABCB1—trigeminal ganglion—germ cell cancer	0.000211	0.0125	CbGeAlD
Mirabegron—BCHE—testis—germ cell cancer	0.00021	0.0123	CbGeAlD
Mirabegron—ABCB1—embryo—germ cell cancer	0.000204	0.012	CbGeAlD
Mirabegron—BCHE—cerebellum—germ cell cancer	0.000194	0.0114	CbGeAlD
Mirabegron—ABCB1—retina—germ cell cancer	0.000181	0.0106	CbGeAlD
Mirabegron—ABCB1—telencephalon—germ cell cancer	0.000166	0.00978	CbGeAlD
Mirabegron—ABCB1—decidua—germ cell cancer	0.000157	0.00927	CbGeAlD
Mirabegron—BCHE—brain—germ cell cancer	0.000157	0.00926	CbGeAlD
Mirabegron—CYP2D6—female gonad—germ cell cancer	0.000157	0.00922	CbGeAlD
Mirabegron—BCHE—lymph node—germ cell cancer	0.000152	0.00895	CbGeAlD
Mirabegron—CYP3A4—endocrine gland—germ cell cancer	0.000148	0.00872	CbGeAlD
Mirabegron—CYP2D6—endocrine gland—germ cell cancer	0.000146	0.00858	CbGeAlD
Mirabegron—CYP2D6—head—germ cell cancer	0.000144	0.00847	CbGeAlD
Mirabegron—CYP2D6—testis—germ cell cancer	0.000139	0.00818	CbGeAlD
Mirabegron—ABCB1—gonad—germ cell cancer	0.000139	0.00816	CbGeAlD
Mirabegron—ABCB1—uterus—germ cell cancer	0.000138	0.00811	CbGeAlD
Mirabegron—ABCB1—pituitary gland—germ cell cancer	0.000135	0.00796	CbGeAlD
Mirabegron—ABCB1—medulla oblongata—germ cell cancer	0.00013	0.00768	CbGeAlD
Mirabegron—CYP2D6—cerebellum—germ cell cancer	0.000128	0.00755	CbGeAlD
Mirabegron—ABCB1—adrenal gland—germ cell cancer	0.000121	0.00711	CbGeAlD
Mirabegron—ABCB1—midbrain—germ cell cancer	0.000119	0.00702	CbGeAlD
Mirabegron—ABCB1—bone marrow—germ cell cancer	0.000117	0.00688	CbGeAlD
Mirabegron—ABCB1—spinal cord—germ cell cancer	0.000116	0.00685	CbGeAlD
Mirabegron—ABCB1—female gonad—germ cell cancer	0.000113	0.00663	CbGeAlD
Mirabegron—ABCB1—endocrine gland—germ cell cancer	0.000105	0.00617	CbGeAlD
Mirabegron—CYP2D6—brain—germ cell cancer	0.000104	0.00614	CbGeAlD
Mirabegron—ABCB1—head—germ cell cancer	0.000103	0.00609	CbGeAlD
Mirabegron—ABCB1—testis—germ cell cancer	9.99e-05	0.00588	CbGeAlD
Mirabegron—ABCB1—cerebellum—germ cell cancer	9.22e-05	0.00543	CbGeAlD
Mirabegron—ABCB1—brain—germ cell cancer	7.49e-05	0.00441	CbGeAlD
Mirabegron—ABCB1—lymph node—germ cell cancer	7.24e-05	0.00426	CbGeAlD
